Marie Frissard

Dr. Marie Frissard


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2026 in Molecules
Verified
Journal Article
Open access
PDF file
MFMarie Frissard
Marie Frissard
MPMarianne Piochon
Marianne Piochon
JLJean Legault
Jean Legault
VMVakhtang Mshilvdadze
Vakhtang Mshilvdadze
NDNassim Djabou
Nassim Djabou
APAndré Pichette
André Pichette
The antibacterial constituents of Rhus typhina drupes remain poorly characterized despite their traditional medicinal use to treat infections. The methanolic extract of R. typhina drupes was evaluated for its antibacterial activity. It inhibited Escherichia coli (IC50 = 12 ± 1 µg/mL) and Staphylococcus aureus (IC50 = 33 ± 8 µg/mL). The extract was subjected to partial bioassay-guided fractionation and phytochemical investigation, leading to the isolation of eighteen compounds whose structures were elucidated by mass spectrometry and nuclear magnetic resonance spectroscopy. A new lupane-type triterpenoid, 3α-hydroxy-3β,25-epoxylup-20(29)-ene (1), was identified and characterized by high-resolution mass spectrometry, IR spectroscopy, and detailed 1D and 2D NMR analyses. HMBC and NOESY correlations supported a lupane-type skeleton bearing a ring-A hemiketal functionality and established its relative stereochemistry. Antibacterial activity was assessed against E. coli and S. aureus for the six isolated compounds available in sufficient quantities for testing. Compound 1 showed activity against S. aureus (IC50 of 0.052 ± 0.004 µM), while its cytotoxicity IC50 toward human WS-1 fibroblasts was >100 µM. Hyperoside (16) was also active against S. aureus (IC50 of 0.48 ± 0.09 µM). These results identify compound 1 as a candidate for further investigation of its antibacterial properties.